Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Adopts Trial-Size Prescriptions For Part D, Delays Implementation

Executive Summary

CMS mandates that Part D plans offer prescriptions filled for less than a 30-day period at a daily cost-sharing rate, with a few stated exceptions, but delays implementation until the 2014 plan year.


Related Content

Study Finds Medication Sync Helps Adherence
Rx Adherence Advocates Target Coming Medicare “Doc Fix” Bill With Policy Recommendations
Merck-Backed Medication Adherence Plan Says Reducing Copays Is Part Of The Solution
Senators Seek “Fresh” Ideas To Fight Health Fraud From Stakeholders
Manufacturers’ Drug Discount Obligation Won’t Be Reduced In Part D Retiree Plans Under CMS Policy
PhRMA Urges Caution In Implementing Part D “Trial-Size” Prescriptions
CMS Takes Second Shot At Mandating “Trial Size” Prescriptions For Part D; Estimates Savings At $2.5 Billion By 2018





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts